- Home
- IGC
IGC
IGC Pharma Inc.
as of 12-12-2025 3:40pm EST
$0.34
+$0.02
+5.12%
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Chart Type:
Time Range:
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | POTOMAC |
| Market Cap: | 33.8M | IPO Year: | N/A |
| Target Price: | $4.13 | AVG Volume (30 days): | 491.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.25 - $0.50 | Next Earning Date: | 11-17-2025 |
| Revenue: | $1,106,000 | Revenue Growth: | -6.51% |
| Revenue Growth (this year): | 3.54% | Revenue Growth (next year): | 15.12% |
AI-Powered IGC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 74.68%
74.68%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest IGC Pharma Inc. News
IGC Breaking Stock News: Dive into IGC Ticker-Specific Updates for Smart Investing
ACCESS Newswire
IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial
📈
AI Sentiment
Highly Positive
8/10
Compare IGC vs Leading Stocks
See how IGC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IGC IGC Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.